Skip to content

Ambulatory 24-h Blood Pressure (ABP) Monitoring and Evaluation of Cardiovascular Risk in Prehypertensive Population

Ambulatory 24-h Blood Pressure (ABP) Monitoring and Evaluation of Cardiovascular Risk in Prehypertensive Population: A Nationwide Population-based Prospective Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073286
Enrollment
Unknown
Registered
2023-07-06
Start date
2023-03-22
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Prehypertension group:None

Sponsors

Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Pre-hypertension: blood pressure ranges from 120-139/80-89 mmHg, and no antihypertensive drugs have been taken in the past month; 2. 35 years=Age=80 years; 3. Permanent residence in the place of residence for 6 months; 4. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.History of cardiovascular disease (including history of myocardial infarction, percutaneous coronary intervention (PCI) or coronary artery bypass surgery (CABG));2.History of stroke (including atherosclerotic cerebral infarction or hemorrhagic stroke, but not excluding lacunar infarction and transient ischemic attack (TIA));3.Diseases associated with secondary hypertension, including renal parenchymal or renal vascular diseases, primary aldosteronism, pheochromocytoma, hyperthyroidism, etc;4.Severe liver, kidney and other organ dysfunction (ALT = 3 times the upper limit of normal, subjects undergoing dialysis treatment, or serum creatinine>2.5 mg/dl [>221 mol/L]);5.Severe acute and chronic infection, immune system disease, hematopoietic or coagulation dysfunction;6.Other serious diseases and life expectancy<12 months;7.Pregnancy or lactation;8.Work on night shift every day;9.Participants in other clinical research trials.

Design outcomes

Primary

MeasureTime frame
Blood pressure progression: prehypertension progression to hypertension;

Secondary

MeasureTime frame
Changes in the function of large arteries ankle brachial index [ABI], pulse wave velocity [PWV];Composite end-point events of the first occurrence of cardio-cerebrovascular events and death;All-cause death;

Countries

China

Contacts

Public ContactWeili Zhang

Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College

zhangweili@fuwaihospital.org+86 139 1052 4025

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026